Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...

With $6 billion left in firepower, Pfizer is planning transactions in the hundreds of millions to the low-billions range, ...

Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.

There is plenty to be wary of with this drugmaker, but there are also reasons to be optimistic.

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing ...

Adaptive Biotechnologies (ADPT) announced two non-exclusive agreements with Pfizer (PFE) to leverage Adaptive’s proprietary T-cell receptor ...

As 2025 closes out, a pair of autoimmune biotechs have eked out separate deals with Big Pharma before year-end, each with a sizable potential payout down the line. | Seattle’s Adaptive Biotechnologies ...

A prescription medicine assistance program offered by Pfizer will help many unemployed Americans continue receiving their prescription medicines when beginning on July 1. MAINTAIN helps newly ...

Texas Attorney General Ken Paxton has sued Pfizer and its drug manufacturer for allegedly providing medicine it knew to be ineffective. In a lawsuit unsealed Monday, Paxton sued Pfizer, Inc., Tris ...

ROCKY MOUNT, N.C. (WTVD) -- Pfizer has restarted the majority of its manufacturing lines at the Rocky Mount facility that was heavily damaged in the tornado that came through back in July. The tornado ...

A tornado heavily damaged a Pfizer pharmaceutical plant in North Carolina on Wednesday night. Luckily, the company said there were no serious injuries. The Associated Press reported that the plant ...